INS and type 2 diabetes mellitus: Moreover, TRAIL serum levels at T1D onset showed an inverse correlation with the insulin requirement at different time points up to 21 months of follow-up (10) and these data were in agreement with an independent study performed on T2D, which showed that circulating levels of TRAIL increased in patients with insulin therapy (13).